Insomnia
IMPORTANCE Insomnia is one of the most prevalent health concerns in the population and in clinical practice. Clinicians may be reluctant to address insomnia because of its many potential causes, unfamiliarity with behavioral treatments, and concerns about pharmacologic treatments. OBJECTIVE To revie...
Gespeichert in:
Veröffentlicht in: | JAMA : the journal of the American Medical Association 2013-02, Vol.309 (7), p.706-716 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 716 |
---|---|
container_issue | 7 |
container_start_page | 706 |
container_title | JAMA : the journal of the American Medical Association |
container_volume | 309 |
creator | Buysse, Daniel J |
description | IMPORTANCE Insomnia is one of the most prevalent health concerns in the population and in clinical practice. Clinicians may be reluctant to address insomnia because of its many potential causes, unfamiliarity with behavioral treatments, and concerns about pharmacologic treatments. OBJECTIVE To review the assessment, diagnosis, and treatment of insomnia in adults. EVIDENCE REVIEW Systematic review to identify and summarize previously published quantitative reviews (meta-analyses) of behavioral and pharmacologic treatments for insomnia. FINDINGS Insomnia is a common clinical condition characterized by difficulty initiating or maintaining sleep, accompanied by symptoms such as irritability or fatigue during wakefulness. The prevalence of insomnia disorder is approximately 10% to 20%, with approximately 50% having a chronic course. Insomnia is a risk factor for impaired function, development of other medical and mental disorders, and increased health care costs. The etiology and pathophysiology of insomnia involve genetic, environmental, behavioral, and physiological factors culminating in hyperarousal. The diagnosis of insomnia is established by a thorough history of sleep behaviors, medical and psychiatric problems, and medications, supplemented by a prospective record of sleep patterns (sleep diary). Quantitative literature reviews (meta-analyses) support the efficacy of behavioral, cognitive, and pharmacologic interventions for insomnia. Brief behavioral interventions and Internet-based cognitive-behavioral therapy both show promise for use in primary care settings. Among pharmacologic interventions, the most evidence exists for benzodiazepine receptor agonist drugs, although persistent concerns focus on their safety relative to modest efficacy. Behavioral treatments should be used whenever possible, and medications should be limited to the lowest necessary dose and shortest necessary duration. CONCLUSIONS AND RELEVANCE Clinicians should recognize insomnia because of its effects on function and health. A thorough clinical history is often sufficient to identify factors that contribute to insomnia. Behavioral treatments should be used when possible. Hypnotic medications are also efficacious but must be carefully monitored for adverse effects. |
doi_str_mv | 10.1001/jama.2013.193 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3632369</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>1653540</ama_id><sourcerecordid>2910248991</sourcerecordid><originalsourceid>FETCH-LOGICAL-a464t-6d1330b12b99791ee6d9095d5a3cb2862dd787919947b645e261c920b64123e93</originalsourceid><addsrcrecordid>eNpVkE1LAzEQhoMotlaPXjx4EY9bM5lkNrkIUvwoFLzoOWR3U93S3a1JK_jvzdJaNQQSmId3Xh7GzoGPgXO4WbjGjQUHHIPBAzYEhTpDZfQhG3JudJZLLQfsJMYFTwcwP2YDgTJdoCEbTNvYNW3tTtnR3C2jP9u9I_b6cP8yecpmz4_Tyd0sc5LkOqMKEHkBojAmN-A9VYYbVSmHZSE0iarKdRoYI_OCpPKCoDSCpz8I9AZH7Habu9oUja9K366DW9pVqBsXvmznavt_0tbv9q37tEgokPqAq11A6D42Pq7totuENnW2gCD7WqQTlW2pMnQxBj_fbwBue3G2F2d7cTaJS_zl31p7-sdUAq53gIulW86Da8s6_nJkOGklEnex5fr4_U5SqCTHb2dle4M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1314997968</pqid></control><display><type>article</type><title>Insomnia</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Buysse, Daniel J</creator><creatorcontrib>Buysse, Daniel J</creatorcontrib><description>IMPORTANCE Insomnia is one of the most prevalent health concerns in the population and in clinical practice. Clinicians may be reluctant to address insomnia because of its many potential causes, unfamiliarity with behavioral treatments, and concerns about pharmacologic treatments. OBJECTIVE To review the assessment, diagnosis, and treatment of insomnia in adults. EVIDENCE REVIEW Systematic review to identify and summarize previously published quantitative reviews (meta-analyses) of behavioral and pharmacologic treatments for insomnia. FINDINGS Insomnia is a common clinical condition characterized by difficulty initiating or maintaining sleep, accompanied by symptoms such as irritability or fatigue during wakefulness. The prevalence of insomnia disorder is approximately 10% to 20%, with approximately 50% having a chronic course. Insomnia is a risk factor for impaired function, development of other medical and mental disorders, and increased health care costs. The etiology and pathophysiology of insomnia involve genetic, environmental, behavioral, and physiological factors culminating in hyperarousal. The diagnosis of insomnia is established by a thorough history of sleep behaviors, medical and psychiatric problems, and medications, supplemented by a prospective record of sleep patterns (sleep diary). Quantitative literature reviews (meta-analyses) support the efficacy of behavioral, cognitive, and pharmacologic interventions for insomnia. Brief behavioral interventions and Internet-based cognitive-behavioral therapy both show promise for use in primary care settings. Among pharmacologic interventions, the most evidence exists for benzodiazepine receptor agonist drugs, although persistent concerns focus on their safety relative to modest efficacy. Behavioral treatments should be used whenever possible, and medications should be limited to the lowest necessary dose and shortest necessary duration. CONCLUSIONS AND RELEVANCE Clinicians should recognize insomnia because of its effects on function and health. A thorough clinical history is often sufficient to identify factors that contribute to insomnia. Behavioral treatments should be used when possible. Hypnotic medications are also efficacious but must be carefully monitored for adverse effects.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.2013.193</identifier><identifier>PMID: 23423416</identifier><identifier>CODEN: JAMAAP</identifier><language>eng</language><publisher>Chicago, IL: American Medical Association</publisher><subject>Antagonist drugs ; Biological and medical sciences ; Cognitive Therapy ; Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes ; Female ; General aspects ; Health behavior ; Humans ; Insomnia ; Medical diagnosis ; Medical sciences ; Medical treatment ; Middle Aged ; Nervous system (semeiology, syndromes) ; Neurology ; Risk Factors ; Side effects ; Sleep Initiation and Maintenance Disorders - complications ; Sleep Initiation and Maintenance Disorders - diagnosis ; Sleep Initiation and Maintenance Disorders - drug therapy ; Sleep Initiation and Maintenance Disorders - epidemiology ; Sleep Initiation and Maintenance Disorders - physiopathology</subject><ispartof>JAMA : the journal of the American Medical Association, 2013-02, Vol.309 (7), p.706-716</ispartof><rights>2014 INIST-CNRS</rights><rights>Copyright American Medical Association Feb 20, 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a464t-6d1330b12b99791ee6d9095d5a3cb2862dd787919947b645e261c920b64123e93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.2013.193$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2013.193$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,230,314,776,780,881,3327,27901,27902,76232,76235</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26906852$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23423416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Buysse, Daniel J</creatorcontrib><title>Insomnia</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><description>IMPORTANCE Insomnia is one of the most prevalent health concerns in the population and in clinical practice. Clinicians may be reluctant to address insomnia because of its many potential causes, unfamiliarity with behavioral treatments, and concerns about pharmacologic treatments. OBJECTIVE To review the assessment, diagnosis, and treatment of insomnia in adults. EVIDENCE REVIEW Systematic review to identify and summarize previously published quantitative reviews (meta-analyses) of behavioral and pharmacologic treatments for insomnia. FINDINGS Insomnia is a common clinical condition characterized by difficulty initiating or maintaining sleep, accompanied by symptoms such as irritability or fatigue during wakefulness. The prevalence of insomnia disorder is approximately 10% to 20%, with approximately 50% having a chronic course. Insomnia is a risk factor for impaired function, development of other medical and mental disorders, and increased health care costs. The etiology and pathophysiology of insomnia involve genetic, environmental, behavioral, and physiological factors culminating in hyperarousal. The diagnosis of insomnia is established by a thorough history of sleep behaviors, medical and psychiatric problems, and medications, supplemented by a prospective record of sleep patterns (sleep diary). Quantitative literature reviews (meta-analyses) support the efficacy of behavioral, cognitive, and pharmacologic interventions for insomnia. Brief behavioral interventions and Internet-based cognitive-behavioral therapy both show promise for use in primary care settings. Among pharmacologic interventions, the most evidence exists for benzodiazepine receptor agonist drugs, although persistent concerns focus on their safety relative to modest efficacy. Behavioral treatments should be used whenever possible, and medications should be limited to the lowest necessary dose and shortest necessary duration. CONCLUSIONS AND RELEVANCE Clinicians should recognize insomnia because of its effects on function and health. A thorough clinical history is often sufficient to identify factors that contribute to insomnia. Behavioral treatments should be used when possible. Hypnotic medications are also efficacious but must be carefully monitored for adverse effects.</description><subject>Antagonist drugs</subject><subject>Biological and medical sciences</subject><subject>Cognitive Therapy</subject><subject>Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes</subject><subject>Female</subject><subject>General aspects</subject><subject>Health behavior</subject><subject>Humans</subject><subject>Insomnia</subject><subject>Medical diagnosis</subject><subject>Medical sciences</subject><subject>Medical treatment</subject><subject>Middle Aged</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Risk Factors</subject><subject>Side effects</subject><subject>Sleep Initiation and Maintenance Disorders - complications</subject><subject>Sleep Initiation and Maintenance Disorders - diagnosis</subject><subject>Sleep Initiation and Maintenance Disorders - drug therapy</subject><subject>Sleep Initiation and Maintenance Disorders - epidemiology</subject><subject>Sleep Initiation and Maintenance Disorders - physiopathology</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkE1LAzEQhoMotlaPXjx4EY9bM5lkNrkIUvwoFLzoOWR3U93S3a1JK_jvzdJaNQQSmId3Xh7GzoGPgXO4WbjGjQUHHIPBAzYEhTpDZfQhG3JudJZLLQfsJMYFTwcwP2YDgTJdoCEbTNvYNW3tTtnR3C2jP9u9I_b6cP8yecpmz4_Tyd0sc5LkOqMKEHkBojAmN-A9VYYbVSmHZSE0iarKdRoYI_OCpPKCoDSCpz8I9AZH7Habu9oUja9K366DW9pVqBsXvmznavt_0tbv9q37tEgokPqAq11A6D42Pq7totuENnW2gCD7WqQTlW2pMnQxBj_fbwBue3G2F2d7cTaJS_zl31p7-sdUAq53gIulW86Da8s6_nJkOGklEnex5fr4_U5SqCTHb2dle4M</recordid><startdate>20130220</startdate><enddate>20130220</enddate><creator>Buysse, Daniel J</creator><general>American Medical Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20130220</creationdate><title>Insomnia</title><author>Buysse, Daniel J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a464t-6d1330b12b99791ee6d9095d5a3cb2862dd787919947b645e261c920b64123e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antagonist drugs</topic><topic>Biological and medical sciences</topic><topic>Cognitive Therapy</topic><topic>Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes</topic><topic>Female</topic><topic>General aspects</topic><topic>Health behavior</topic><topic>Humans</topic><topic>Insomnia</topic><topic>Medical diagnosis</topic><topic>Medical sciences</topic><topic>Medical treatment</topic><topic>Middle Aged</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Risk Factors</topic><topic>Side effects</topic><topic>Sleep Initiation and Maintenance Disorders - complications</topic><topic>Sleep Initiation and Maintenance Disorders - diagnosis</topic><topic>Sleep Initiation and Maintenance Disorders - drug therapy</topic><topic>Sleep Initiation and Maintenance Disorders - epidemiology</topic><topic>Sleep Initiation and Maintenance Disorders - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buysse, Daniel J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buysse, Daniel J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insomnia</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2013-02-20</date><risdate>2013</risdate><volume>309</volume><issue>7</issue><spage>706</spage><epage>716</epage><pages>706-716</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><coden>JAMAAP</coden><abstract>IMPORTANCE Insomnia is one of the most prevalent health concerns in the population and in clinical practice. Clinicians may be reluctant to address insomnia because of its many potential causes, unfamiliarity with behavioral treatments, and concerns about pharmacologic treatments. OBJECTIVE To review the assessment, diagnosis, and treatment of insomnia in adults. EVIDENCE REVIEW Systematic review to identify and summarize previously published quantitative reviews (meta-analyses) of behavioral and pharmacologic treatments for insomnia. FINDINGS Insomnia is a common clinical condition characterized by difficulty initiating or maintaining sleep, accompanied by symptoms such as irritability or fatigue during wakefulness. The prevalence of insomnia disorder is approximately 10% to 20%, with approximately 50% having a chronic course. Insomnia is a risk factor for impaired function, development of other medical and mental disorders, and increased health care costs. The etiology and pathophysiology of insomnia involve genetic, environmental, behavioral, and physiological factors culminating in hyperarousal. The diagnosis of insomnia is established by a thorough history of sleep behaviors, medical and psychiatric problems, and medications, supplemented by a prospective record of sleep patterns (sleep diary). Quantitative literature reviews (meta-analyses) support the efficacy of behavioral, cognitive, and pharmacologic interventions for insomnia. Brief behavioral interventions and Internet-based cognitive-behavioral therapy both show promise for use in primary care settings. Among pharmacologic interventions, the most evidence exists for benzodiazepine receptor agonist drugs, although persistent concerns focus on their safety relative to modest efficacy. Behavioral treatments should be used whenever possible, and medications should be limited to the lowest necessary dose and shortest necessary duration. CONCLUSIONS AND RELEVANCE Clinicians should recognize insomnia because of its effects on function and health. A thorough clinical history is often sufficient to identify factors that contribute to insomnia. Behavioral treatments should be used when possible. Hypnotic medications are also efficacious but must be carefully monitored for adverse effects.</abstract><cop>Chicago, IL</cop><pub>American Medical Association</pub><pmid>23423416</pmid><doi>10.1001/jama.2013.193</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0098-7484 |
ispartof | JAMA : the journal of the American Medical Association, 2013-02, Vol.309 (7), p.706-716 |
issn | 0098-7484 1538-3598 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3632369 |
source | MEDLINE; American Medical Association Journals |
subjects | Antagonist drugs Biological and medical sciences Cognitive Therapy Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes Female General aspects Health behavior Humans Insomnia Medical diagnosis Medical sciences Medical treatment Middle Aged Nervous system (semeiology, syndromes) Neurology Risk Factors Side effects Sleep Initiation and Maintenance Disorders - complications Sleep Initiation and Maintenance Disorders - diagnosis Sleep Initiation and Maintenance Disorders - drug therapy Sleep Initiation and Maintenance Disorders - epidemiology Sleep Initiation and Maintenance Disorders - physiopathology |
title | Insomnia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T22%3A13%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insomnia&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Buysse,%20Daniel%20J&rft.date=2013-02-20&rft.volume=309&rft.issue=7&rft.spage=706&rft.epage=716&rft.pages=706-716&rft.issn=0098-7484&rft.eissn=1538-3598&rft.coden=JAMAAP&rft_id=info:doi/10.1001/jama.2013.193&rft_dat=%3Cproquest_pubme%3E2910248991%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1314997968&rft_id=info:pmid/23423416&rft_ama_id=1653540&rfr_iscdi=true |